Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
glezisim 10 mg/40 mg tablety
glenmark pharmaceuticals s.r.o., Česká republika - simvastatín a ezetimib - 31 - hypolipidaemica
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
glezisim 10 mg/10 mg tablety
glenmark pharmaceuticals s.r.o., Česká republika - simvastatín a ezetimib - 31 - hypolipidaemica
Európska únia -
slovenčina -
EMA (European Medicines Agency)
onureg
bristol-myers squibb pharma eeig - azacitidín - leukémia, myeloidná, akútna - antineoplastické činidlá - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
Európska únia -
slovenčina -
EMA (European Medicines Agency)
ebglyss
almirall, s.a. - lebrikizumab - dermatitída, atopická - ostatné dermatologické prípravky - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.